Presentation

Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS

Presenter: 78830|Thomas Povsic

August 09, 2012

REGISTER for free or LOG IN to view this content

Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS

Coronary

Factoid

Up Next

Presentation

Real-time MRI-Guided Right Heart Catheterization In Adults Using Passive Catheters

Presenter: K. Ratnayaka

August 10, 2012

More slides +

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Presenter: Corrado Tamburino

April 25, 2012

Presentation TCTAP 2012

When is TAVR Not Cost-Effective?

Presenter: David J. Cohen

April 25, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.